Reuters: Health News: UK health cost body backs Novartis asthma drug in fresh U-turn

UK health cost body backs Novartis asthma drug in fresh U-turn

LONDON (Reuters) - Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair afte...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/2q40iSqegs4/us-novartis-britain-xolair-idUSBRE92600L20130307